ArticleJournal of hepatocellular carcinoma2024

Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Liwei Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.